Hendrik Peter Scholl - 01 Oct 2026 Form 4 Insider Report for BELITE BIO, INC (BLTE)

Reporting relationship: Chief Medical Officer
Issuer ticker: BLTE
Reported as of: 01 Oct 2026
Net transaction value: -$82,659
SEC form: 4
Accepted by SEC: 05 Oct 2026, 19:27:38 UTC
Prior SEC filing: 22 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Hendrik Peter Scholl

Filing notes and source

Key filing fact

Hendrik Peter Scholl filed Form 4 for BELITE BIO, INC (BLTE) on 05 Oct 2026.

Key facts

This page summarizes Hendrik Peter Scholl's Form 4 filing for BELITE BIO, INC (BLTE).
8 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 05 Oct 2026, 19:27.

Change

Previous filing in this sequence was filed on 22 Jun 2026.
Current net transaction value: -$82,659.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002113223 Primary reporting owner

Scholl Hendrik Peter

Relationship: Chief Medical Officer
Address: GOTTHARDSTRASSE 26, ZUG, SWITZERLAND
Signature: /s/ Hendrik Peter Scholl
Signature date: 05 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLTE transaction

American depositary share

Sale

Transaction value: $32,725
Shares: -200
Change %: -1.3%
Price: $163.62
Shares after: 14,800
Date: 01 Oct 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F2, F3

BLTE transaction

American depositary share

Sale

Transaction value: $3,951
Shares: -24
Change %: -0.16%
Price: $164.64
Shares after: 14,776
Date: 01 Oct 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F2, F4

BLTE transaction

American depositary share

Sale

Transaction value: $19,859
Shares: -120
Change %: -0.81%
Price: $165.49
Shares after: 14,656
Date: 01 Oct 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F2, F5

BLTE transaction

American depositary share

Sale

Transaction value: $8,322
Shares: -50
Change %: -0.34%
Price: $166.44
Shares after: 14,606
Date: 01 Oct 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F2, F6

BLTE transaction

American depositary share

Sale

Transaction value: $13,072
Shares: -78
Change %: -0.53%
Price: $167.59
Shares after: 14,528
Date: 01 Oct 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F2, F7

BLTE transaction

American depositary share

Sale

Transaction value: $2,019
Shares: -12
Change %: -0.08%
Price: $168.21
Shares after: 14,516
Date: 01 Oct 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F2, F8

BLTE transaction

American depositary share

Sale

Transaction value: $2,371
Shares: -14
Change %: -0.1%
Price: $169.36
Shares after: 14,502
Date: 01 Oct 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F2, F9

BLTE transaction

American depositary share

Sale

Transaction value: $340
Shares: -2
Change %: -0.01%
Price: $170.02
Shares after: 14,500
Date: 01 Oct 2026
Ownership: By Bioptima Ltd.
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 9 footnotes

Footnote F1

Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.

Footnote F2

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/25/2026.

Footnote F3

Represents the weighted average price of shares sold at prices that ranged from $163.6 to $163.65. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F4

Represents the weighted average price of shares sold at prices that ranged from $164.41 to $164.96. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F5

Represents the weighted average price of shares sold at prices that ranged from $165 to $165.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F6

Represents the weighted average price of shares sold at prices that ranged from $166.06 to $166.77. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F7

Represents the weighted average price of shares sold at prices that ranged from $167 to $167.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F8

Represents the weighted average price of shares sold at prices that ranged from $168.03 to $168.42. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F9

Represents the weighted average price of shares sold at prices that ranged from $169.18 to $169.51. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.